Calgary, Alberta – TheNewswire - December 18, 2020 – Voyageur Pharmaceuticals Ltd. (TSXV:VM) USA (OTC:VYYRF) (the "Company" or "Voyageur") is please to announce the filing of its further updated Frances Creek Barite Project NI 43-101 Technical Report (the "Report") on SEDAR. The Report supersedes previous NI 43-101 reports filed by the Company on SEDAR and dated July 11, 2018 and February 7, 2019. The Report was co-authored by Craig Dunn, P. Geol. and Murray Lytle, Ph.D., P. Eng., is entitled "Technical Report: Voyageur Pharmaceuticals Ltd. Frances Creek Barite Early-Stage Exploration Project Radium, BC" and is dated December 18, 2020.
About Voyageur
Voyageur Pharmaceuticals Ltd. is Canadian public company listed on the TSX Venture Exchange under the trading symbol VM. Voyageur is focused on the development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The near-term focus is developing barium, iodine radio-contrast products and fullerene-based pharmaceutical products.
Voyageur’s goal is to initially generate the positive cash flow from operations using third party GMP pharmaceutical manufacturers in Canada and in India. Ultimately, Voyageur has plans to build all the required infrastructure to become 100% self-sufficient with all manufacturing.
Voyageur owns a 100% interest in three barium sulfate (barite) projects including two properties suitable in grade for the industrial barite marketplace, including interests in a high-grade iodine, lithium & bromine brine project located in Utah, USA.
Voyageur is moving forward with its business plan of becoming the only fully integrated company in the radio-contrast medical field, by controlling all primary input costs under the motto of:
"From the Earth to the Bottle"
www.voyageurpharmaceuticals.ca
For Further Media Information or to set up an interview, please contact:
Brent Willis
President & CEO
Ron Love
CFO
T 403.818.6086
Reader Advisory
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.
Copyright (c) 2020 TheNewswire - All rights reserved.
